An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Conclusion

Conclude your understanding of lymphoma with an in-depth look at its signs and symptoms, from common indicators to subtle clues.

Speaker : Dr Suvir Singh

Expert Group meeting with the management of EGFR mutation positive NSCLC - Part IV

Expert panel discusses targeted therapies and strategies for managing EGFR mutation-positive non-small cell lung cancer.

Speakers : Dr. Vineet Govinda Gupta ( Moderator ) ,Dr. Atul Sharma ( Panelist ) ,Dr. Abhishek Bansal ( Panelist )

Dacomitinib Case Presentation: Baseline Treatment and Current Status

Explore Dr. Viraj Nevrekar’s expert insights on Dacomitinib in NSCLC, covering baseline treatment approaches, efficacy, and real-world case studies.

Speakers : Dr Viraj Nevrekar- (Moderator)

Dissecting Molecular differences between EGFR Exon 19 deletion and Exon 21 L858R Mutations

Explore Dr. Viraj Nevrekar’s expert analysis on the molecular and clinical differences between EGFR Exon 19 deletion and Exon 21 L858R mutations in NSCLC.

Speakers : Dr. Viraj Nevrekar

First Line Combination Therapy- The Overall Survival Data in NSCLC Patients

Dr. Viraj Nevrekar discusses first-line combination therapy and overall survival data in NSCLC, covering immunotherapy, targeted therapy, and chemotherapy.

Speakers : Dr. Viraj Nevrekar

L858R Mutation- An Overview of Retrospective Cohort Study in Advanced NSCLC Patients

Explore Dr. Viraj Nevrekar’s analysis of the L858R mutation in advanced NSCLC through a retrospective cohort study, covering treatment outcomes, survival trends, and clinical outcomes

Speakers : Dr. Viraj Nevrekar

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part V

In this webinar, a detailed discussion is done on CROWN trial update: Optimizing 1st-line ALK+ mNSCLC management.

Speakers : Dr Srujna Joga ( Expert Panel ) ,Dr AP Dubey ( Expert Panel ) ,Dr Atul Sharma ( Expert Panel ) ,Dr Jyoti Wadhwa ( Moderator )

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part IV

In this webinar, a detailed discussion is done on CROWN trial update: Optimizing 1st-line ALK+ mNSCLC management.

Speakers : Dr Srujna Joga ( Expert Panel ) ,Dr AP Dubey ( Expert Panel ) ,Dr Atul Sharma ( Expert Panel ) ,Dr Jyoti Wadhwa ( Moderator )

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)

In this webinar, a detailed discussion is done on CROWN trial update: Optimizing 1st-line ALK+ mNSCLC management.

Speakers : Dr Jyoti Wadhwa ( Moderator ) ,Dr Atul Sharma ( Expert Panel ) ,Dr AP Dubey ( Expert Panel ) ,Dr Srujna Joga ( Expert Panel )

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part II

In this webinar, a detailed discussion is done on CROWN trial update: Optimizing 1st-line ALK+ mNSCLC management.

Speakers : Dr Srujna Joga ( Expert Panel ) ,Dr AP Dubey ( Expert Panel ) ,Dr Atul Sharma ( Expert Panel ) ,Dr Jyoti Wadhwa ( Moderator )

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part III

In this webinar, a detailed discussion is done on CROWN trial update: Optimizing 1st-line ALK+ mNSCLC management.

Speakers : Dr Srujna Joga ( Expert Panel ) ,Dr AP Dubey ( Expert Panel ) ,Dr Atul Sharma ( Expert Panel ) ,Dr Jyoti Wadhwa ( Moderator )


Recommended News For You

There has been a recent decrease in the risk of a recurrence of colorectal cancer in stage I to III cases.

Artificial intelligence is assisting in the earlier detection and treatment of breast cancer.

EU Flags Shortage Of Schizophrenia Drug Injections Due to Manufacturing Issues

finding fresh approaches to treating diffuse midline gliomas.

FDA approves Blenrep for relapsed or refractory multiple myeloma

Novel Agent Effective for Cancer Wasting Disorder

Women are more susceptible to the stress caused by inflation.

Recommended Articles For You

The Pros and Cons of Steroid Therapy for ITP 

Integrated Techniques in Oncology in the Digital Era 

Unlocking the Potential of Elotuzumab: A Promising New Cancer Treatment 

Practical Applications in Hematology Across Clinical Settings 
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

A study suggests that you should disregard the "pack-years" when determining your eligibility for lung cancer screening.

2.

Why Are These Bones and Teeth Where They Shouldn't Be?

3.

Survey: Record Numbers of US Adults Report Depression.

4.

Talc Powder Not Linked to Lung Cancer in Women

5.

Multidrug Regimen Could Change Treatment Landscape for Relapsed/Refractory DLBCL

1.

Digital Oncology Ecosystems Integrating Longitudinal Patient Trajectories: Transforming Cancer Care through Data-Driven Innovation

2.

Trends in Incidence, Care, and Surgery for Medullary Thyroid Cancer: A Review

3.

Unveiling the Mystery of Epstein-Barr Virus: What We Know So Far

4.

Contemporary Frameworks in Oncology Across Clinical Settings

5.

The Importance of Corrected Calcium Levels in Managing Health Conditions 

1.

International Cancer Conference

2.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VII

2.

Managing Common Side Effects During Cancer Treatment

3.

The Landscape of First-Line Treatment for Urothelial Carcinoma- The Conclusion

4.

How Iron Deficiency Can Affect Energy and Concentration

5.

L858R Mutation- An Overview of Retrospective Cohort Study in Advanced NSCLC Patients


Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot